| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8525887 | Biomedicine & Pharmacotherapy | 2018 | 10 Pages |
Abstract
The results of the current study demonstrate that oncogene miR-566 is a potential biomarker not only for diagnosis but also for prognosis for RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Xiang Pan, Jing Quan, Zuwei Li, Liwen Zhao, Liang Zhou, Jinling Xu, Weijie Xu, Xin Guan, Hang Li, Shangqi Yang, Yaoting Gui, Yongqing Lai,